Osteoarthritis Mechanisms and Therapeutic Strategies

Osteoarthritis is a multifactorial disorder characterised by progressive degradation of articular cartilage, remodelling of subchondral bone and low-grade inflammation of the synovial lining. Mechanical stress, biochemical mediators and genetic predisposition converge on chondrocytes, driving extracellular matrix breakdown and cell death. Subchondral bone sclerosis and aberrant osteoclast activity alter load distribution, while synovitis amplifies the release of pro-inflammatory cytokines and nerve growth factor, sensitising joint nociceptors. Pain arises through peripheral sensitisation and neuroplastic changes in central pathways, often persisting despite modest radiographic change. Therapeutic strategies increasingly target both structural progression and symptomatic relief. Disease-modifying approaches aim to restore chondrocyte homeostasis, inhibit ferroptosis and endoplasmic reticulum stress, or modulate osteoclastogenesis. Pain management has evolved beyond non-steroidal anti-inflammatory agents to include blockade of key ion channels and growth factor signalling. Emerging regenerative and mechanical interventions seek to rebalance joint mechanics and promote tissue repair. A holistic paradigm embraces early intervention, personalised molecular therapy and biomechanical optimisation to alleviate pain and delay joint replacement on a global scale.

Research from Nature Portfolio

Recent studies have revealed that conditional deletion of the mechanosensitive ion channel Piezo2 in nociceptors markedly reduces mechanical pain sensitivity in experimental osteoarthritis, highlighting Piezo2 as a non-opioid target for pain control. Single-cell transcriptomics confirmed co-expression of Piezo2 with nerve growth factor receptors in joint-innervating neurons, underscoring a mechanism for growth factor-mediated sensitisation. In parallel, application of controlled mechanical loading to osteoarthritic knee joints has been shown to suppress osteoclast differentiation in subchondral bone, preserving bone architecture and reducing cartilage degeneration. This mechanical therapy acts through Wnt signalling to inhibit bone resorption, demonstrating that targeted biomechanical stimuli can serve as a disease-modifying approach.

Osteoarthritis Mechanisms and Therapeutic Strategies publication trend

The graph below shows the total number of articles in osteoarthritis mechanisms and therapeutic strategies across all publications each year (not limited to Nature Index journals).

Technical terms

Chondrocyte: specialised cell responsible for synthesis and maintenance of cartilage matrix.

Synovitis: inflammation of the synovial membrane lining of a joint.

Subchondral bone: the layer of bone immediately beneath the cartilage surface in a joint.

Nociceptor: sensory nerve ending that detects noxious or damaging stimuli and transmits pain signals.

Ferroptosis: iron-dependent form of regulated cell death characterised by lipid peroxidation.

Piezo2: mechanosensitive ion channel in sensory neurons that mediates detection of mechanical stimuli.

TRPV1: transient receptor potential vanilloid ion channel activated by heat and chemical ligands, involved in pain signalling.

References

1. Piezo2 expressing nociceptors mediate mechanical sensitization in experimental osteoarthritis. Nature Communications (2023).
2. Knee loading inhibits osteoclast lineage in a mouse model of osteoarthritis. Scientific Reports (2016).
3. Near Infrared Responsive Gold Nanorods Attenuate Osteoarthritis Progression by Targeting TRPV1. Advanced Science (2024).
4. Glucagon-like peptide-1 receptor regulates endoplasmic reticulum stress-induced apoptosis and the associated inflammatory response in chondrocytes and the progression of osteoarthritis in rat. Cell Death & Disease (2018).
5. Mechanisms of Osteoarthritic Pain. Studies in Humans and Experimental Models. Frontiers in Molecular Neuroscience (2017).